|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Series A Convertible Preferred Stock | (1) | 02/16/2011 | C | 500,000 | (6) | (7) | Common Stock | 682,904 | (1) | 0 | I | See Footnote (2) | |||
Series B Convertible Preferred Stock | (3) | 02/16/2011 | C | 218,750 | (6) | (7) | Common Stock | 328,064 | (3) | 0 | I | See Footnote (2) | |||
Series C Convertible Preferred Stock | (4) | 02/16/2011 | C | 810,129 | (6) | (7) | Common Stock | 810,129 | (4) | 0 | I | See Footnote (2) | |||
Convertible Promissory Note | (8) | 02/16/2011 | J | $ 644,556 | (9) | (9) | Common Stock | 163,914 | (9) | $ 1,097,487 | I | See Footnote (2) | |||
Warrant to Purchase Series C Preferred Stock | (8) | 02/16/2011 | J | 40,865 | (10) | (11) | Series C Preferred | 40,865 | (10) | 69,588 | I | See Footnote (2) | |||
Convertible Promissory Note | (5) | 02/16/2011 | C | $ 1,097,487 | (5) | (5) | Common Stock | 279,097 | (5) | 0 | I | See Footnote (2) | |||
Warrant to Purchase Series C Preferred Stock | (10) | 02/16/2011 | X | 69,588 | (10) | (12) | Series C Preferred | 69,588 | (10) | 0 | I | See Footnote (2) | |||
Series C Convertible Preferred Stock | (4) | 02/16/2011 | X | 69,588 (13) | (6) | (7) | Common Stock | 69,588 | (4) | 0 | I | See Footnote (2) | |||
Series C Convertible Preferred Stock | (4) | 02/16/2011 | S | 54,875 (13) | (6) | (7) | Common Stock | 54,875 | $ 5 | 14,713 | I | See Footnote (2) | |||
Series C Convertible Preferred Stock | (4) | 02/16/2011 | C | 14,713 | (6) | (7) | Common Stock | 14,713 | (4) | 0 | I | See Footnote (2) |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
NOHRA GUY P ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO, CA 94111 |
X | X |
/s/ Guy Nohra | 02/18/2011 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The shares reflect the automatic conversion of 500,000 shares of the Issuer's Series A Preferred Stock for 682,904 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering. |
(2) | These shares are held by ACP IV, LP ("ACPIV"). Guy Nohra, a Director of the Issuer, is also a Director of ACMP IV, LLC ("ACMPIV"), which is the general partner of ACPIV. Mr. Nohra may be deemed to share voting and dispositive power with respect to all securities of the Issuer held by ACPIV with the directors of ACMPIV but disclaims beneficial ownership of such securities except to the extent of his proportionate pecuniary interest therein. |
(3) | The shares reflect the automatic conversion of 218,750 shares of Series B Preferred Stock for 328,064 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering. |
(4) | The shares reflect the automatic conversion of shares of the Issuer's Series C Preferred Stock into Common Stock on a one-to-one basis upon the closing of the Issuer's initial public offering. |
(5) | Notes and accrued interest in the aggregate of $1,116,388.59 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80% of the per share price of the Common Stock sold in the Issuer's initial public offering. |
(6) | Immediately convertible into shares of the Issuer's Common Stock. |
(7) | These shares have no expiration date. |
(8) | Pursuant to Note and Warrant Transfer Agreement dated February 16, 2011, ACP IV, L.P. transferred (i)a convertible promissory note in the amount of $655,656.79 including accrued interest and (ii)an associated warrant to purchase preferred stock on the Issuer, exercisable into 40,865 shares of Series C Preferred Stock. |
(9) | Principal amount plus interest converts automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80% of the per share price of the Common Stock sold in the Issuer's initial public offering. |
(10) | The exercise price is $3.9428 per share and immediately exercisable prior to and contingent upon the closing of the Issuer's initial public offering. |
(11) | Pursuant to its terms, the warrant would terminate at the closing of the Issuer's initial public offering. In the event the Issuer's public offering did not occur, the warrant would have terminated on September 14, 2017, unless earlier terminated in accordance with its terms, in a liquidation or change of control transaction. |
(12) | Pursuant to its terms, the warrant would terminate at the closing of the Issuer's intial public offering. Holder has elected to net exercise the warrants contingent upon and effective immediately prior to the closing of the Issuer's initial public offering of common stock. |
(13) | These shares reflect the net exercise of the Series C warrant pursuant to the terms of the warrant into 14,713 shares of the Issuer's Series C Preferred Stock. |